<?xml version="1.0" encoding="utf-8"?>
<journal>
<title>Iranian Biomedical Journal</title>
<title_fa>مجله بیومدیکال ایران</title_fa>
<short_title>IBJ</short_title>
<subject>Basic Sciences</subject>
<web_url>http://ibj.pasteur.ac.ir</web_url>
<journal_hbi_system_id>1</journal_hbi_system_id>
<journal_hbi_system_user>admin</journal_hbi_system_user>
<journal_id_issn>1028-852X</journal_id_issn>
<journal_id_issn_online>2008-823X</journal_id_issn_online>
<journal_id_pii>-</journal_id_pii>
<journal_id_doi>10.61882/ibj</journal_id_doi>
<journal_id_iranmedex></journal_id_iranmedex>
<journal_id_magiran></journal_id_magiran>
<journal_id_sid>-</journal_id_sid>
<journal_id_nlai>8888</journal_id_nlai>
<journal_id_science>-</journal_id_science>
<language>en</language>
<pubdate>
	<type>jalali</type>
	<year>1404</year>
	<month>11</month>
	<day>1</day>
</pubdate>
<pubdate>
	<type>gregorian</type>
	<year>2026</year>
	<month>2</month>
	<day>1</day>
</pubdate>
<volume>30</volume>
<number>2</number>
<publish_type>online</publish_type>
<publish_edition>1</publish_edition>
<article_type>fulltext</article_type>
<articleset>
	<article>


	<language>other</language>
	<article_id_doi></article_id_doi>
	<title_fa></title_fa>
	<title>Multiphysics Simulation of the Synergistic Interaction Between Plasma-Based Radiosensitization and Liquid 131Cs Balloon Brachytherapy in GBM</title>
	<subject_fa> Related Fields</subject_fa>
	<subject>Related Fields</subject>
	<content_type_fa>کنگره</content_type_fa>
	<content_type>Congress</content_type>
	<abstract_fa></abstract_fa>
	<abstract>&lt;div style=&quot;text-align: justify;&quot;&gt;&lt;span style=&quot;font-family:Times New Roman;&quot;&gt;&lt;span style=&quot;font-size:11pt&quot;&gt;&lt;span style=&quot;line-height:normal&quot;&gt;&lt;span style=&quot;unicode-bidi:embed&quot;&gt;&lt;b&gt;&lt;span style=&quot;font-size:10.5pt&quot;&gt;Introduction: &lt;/span&gt;&lt;/b&gt;&lt;span style=&quot;font-size:10.5pt&quot;&gt;Glioblastoma multiforme&lt;/span&gt;&lt;span style=&quot;font-size:10.5pt&quot;&gt; (&lt;/span&gt;&lt;span style=&quot;font-size:10.5pt&quot;&gt;GBM) is a highly aggressive primary brain tumor known for its significant resistance to radiation treatment. This resistance is primarily due to efficient repair of DNA double-strand break (DSB), hypoxic microenvironments (with oxygen partial pressure, pO₂ &lt; 10 mmHg), and hypermethylation of the MGMT promoter. Standard treatment typically involves maximal safe surgical resection, external beam radiotherapy (60 Gy&lt;/span&gt;&lt;span dir=&quot;RTL&quot; lang=&quot;AR-SA&quot; style=&quot;font-size:10.5pt&quot;&gt;/&lt;/span&gt;&lt;span style=&quot;font-size:10.5pt&quot;&gt;30 fractions), and the chemotherapy agent temozolomide, providing a median survival of only 14.6 months. To enhance the cytotoxic effects of ionizing radiation on residual tumor cells within a 1 cm clinical target volume, this study employs a multiphysics simulation that integrates plasma-based radiosensitization with liquid &lt;sup&gt;131&lt;/sup&gt;Cs balloon brachytherapy.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;br&gt;
&lt;span style=&quot;font-size:11pt&quot;&gt;&lt;span style=&quot;line-height:normal&quot;&gt;&lt;span style=&quot;unicode-bidi:embed&quot;&gt;&lt;b&gt;&lt;span style=&quot;font-size:10.5pt&quot;&gt;Materials and Methods: &lt;/span&gt;&lt;/b&gt;&lt;span style=&quot;font-size:10.5pt&quot;&gt;The photon transport from a silicone balloon (0.2 mm wall thickness, 3 cm diameter) filled with liquid &lt;sup&gt;131&lt;/sup&gt;Cs (half-life = 9.7 days, energy &amp;asymp; 29 keV) was modeled using Using MCNPX 2.6. This model aims to deliver 60&lt;/span&gt; &lt;span style=&quot;font-size:10.5pt&quot;&gt;Gy at a distance of 1 cm from the balloon its surface (with V₁₀₀ = 92%, D₉₀ = 58 Gy, and BED₁₀ &lt; 100 Gy). Additionally, COMSOL Multiphysics 6.2 simulated an argon dielectric-barrier discharge (10 kV, 10 kHz, 0.1 L/min for 60 seconds) producing reactive oxygen species (ROS) and nitrogen species such as O₃, &amp;bull;OH, H₂O₂, and nitric oxide, with penetration depths of 1.2&amp;ndash;1.8 mm and &lt;10% deviation from experimental validation.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;br&gt;
&lt;span style=&quot;font-size:11pt&quot;&gt;&lt;span style=&quot;line-height:normal&quot;&gt;&lt;span style=&quot;unicode-bidi:embed&quot;&gt;&lt;b&gt;&lt;span style=&quot;font-size:10.5pt&quot;&gt;Results and Discussion: &lt;/span&gt;&lt;/b&gt;&lt;span style=&quot;font-size:10.5pt&quot;&gt;Linear-quadratic modeling (&amp;alpha;₀ = 0.25Gy⁻&amp;sup1;, &amp;beta; = 0.03Gy⁻&amp;sup2;) that incorporated CAP-induced &amp;alpha; enhancement (&amp;Delta;&amp;alpha;/&amp;alpha;₀ = 28%) predicted a 37% reduction in survival of U87MG cell (SF&lt;sub&gt;(combined)&lt;/sub&gt; = 0.15 vs. 0.24) and a 35% increase in apoptosis, as indicated by &amp;gamma;-H2AX and caspase-3 activation. Plasma-activated liquids (PAL) further improved the diffusion of ROS by ~50% without inducing significant thermal effects (&amp;Delta;T &lt; 1.5&amp;deg;C). Overall, CAP and PAL act as effective radiosensitizers, amplifying oxidative damage to DSB and improving the therapeutic efficacy of &lt;sup&gt;131&lt;/sup&gt;Cs brachytherapy while maintaining safe doses of normal tissue. &lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;br&gt;
&lt;span style=&quot;font-size:11pt&quot;&gt;&lt;span style=&quot;line-height:normal&quot;&gt;&lt;span style=&quot;unicode-bidi:embed&quot;&gt;&lt;b&gt;&lt;span style=&quot;font-size:10.5pt&quot;&gt;Conclusion: &lt;/span&gt;&lt;/b&gt;&lt;span style=&quot;font-size:10.5pt&quot;&gt;Our findings support the development of a hybrid intraoperative treatment system and its future preclinical application in trials.&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;&lt;br&gt;
&amp;nbsp;&lt;/div&gt;
&lt;br&gt;
&amp;nbsp;
&lt;table align=&quot;center&quot; border=&quot;1&quot; cellpadding=&quot;0&quot; cellspacing=&quot;0&quot;&gt;
	&lt;tbody&gt;
		&lt;tr&gt;
			&lt;td&gt;&lt;/td&gt;
			&lt;td&gt;&lt;img alt=&quot;&quot; height=&quot;84&quot; src=&quot;./files/site1/images/Picture1.jpg&quot; width=&quot;507&quot; &gt;&lt;/td&gt;
			&lt;td&gt;&lt;/td&gt;
		&lt;/tr&gt;
	&lt;/tbody&gt;
&lt;/table&gt;</abstract>
	<keyword_fa></keyword_fa>
	<keyword>131Cs balloon brachytherapy, Cold atmospheric plasma, COMSOL multiphysics, GBM, MCNPx simulation, Plasma-based radiosensitization</keyword>
	<start_page>7</start_page>
	<end_page>7</end_page>
	<web_url>http://ibj.pasteur.ac.ir/browse.php?a_code=A-10-1-869&amp;slc_lang=other&amp;sid=1</web_url>


<author_list>
	<author>
	<first_name>Amir </first_name>
	<middle_name></middle_name>
	<last_name>Kazemi</last_name>
	<suffix></suffix>
	<first_name_fa></first_name_fa>
	<middle_name_fa></middle_name_fa>
	<last_name_fa></last_name_fa>
	<suffix_fa></suffix_fa>
	<email></email>
	<code></code>
	<orcid></orcid>
	<coreauthor>Yes
</coreauthor>
	<affiliation></affiliation>
	<affiliation_fa></affiliation_fa>
	 </author>


	<author>
	<first_name>Hosein </first_name>
	<middle_name></middle_name>
	<last_name>Poorbaygi</last_name>
	<suffix></suffix>
	<first_name_fa></first_name_fa>
	<middle_name_fa></middle_name_fa>
	<last_name_fa></last_name_fa>
	<suffix_fa></suffix_fa>
	<email></email>
	<code></code>
	<orcid></orcid>
	<coreauthor>No</coreauthor>
	<affiliation></affiliation>
	<affiliation_fa></affiliation_fa>
	 </author>


	<author>
	<first_name>Somayeh </first_name>
	<middle_name></middle_name>
	<last_name>Akbari Koradeh</last_name>
	<suffix></suffix>
	<first_name_fa></first_name_fa>
	<middle_name_fa></middle_name_fa>
	<last_name_fa></last_name_fa>
	<suffix_fa></suffix_fa>
	<email></email>
	<code></code>
	<orcid></orcid>
	<coreauthor>No</coreauthor>
	<affiliation></affiliation>
	<affiliation_fa></affiliation_fa>
	 </author>


</author_list>


	</article>
</articleset>
</journal>
